A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells

Cited by (508)

Items 201–300 of 508

1. The march of pluripotent stem cells in cardiovascular regenerative medicine
   Haissam Abou-Saleh, Fouad Anthony Zouein, Ahmed Fawzy EL‐Yazbi, Despina Sanoudou, Christophe Michel Raynaud, Christopher Rao, Gianfranco Pintus, Hassan Dehaini, Ali Hussein Eid · 2018 · Stem Cell Research & Therapy
2. Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs)
   Peng-Yuan Wang, S. S. Hung, H. Thissen, P. Kingshott, R. C. Wong · 2016 · Scientific Reports
3. KLF4 N-Terminal Variance Modulates Induced Reprogramming to Pluripotency
   Shin-Il Kim, Fabian Oceguera-Yañez, Ryoko Hirohata, Sara Linker, K. Okita, Yasuhiro Yamada, Takuya Yamamoto, S. Yamanaka, K. Woltjen · 2015 · Stem Cell Reports
4. iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins
   Y. Shamis, K. Hewitt, S. E. Bear, Addy Alt‐Holland, H. Qari, Mariam Margvelashvilli, Elana B. Knight, Avi Smith, J. Garlick · 2012 · In vitro Cellular & Developmental Biology-Animal
5. Induced pluripotency of mouse and human somatic cells.
   N. Maherali, K. Hochedlinger · 2008 · Cold Spring Harbor Symposia on Quantitative Biology
6. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation
   J. Lewandowski, M. Kurpisz · 2016 · Archivum Immunologiae et Therapiae Experimentalis
7. How far are induced pluripotent stem cells from the clinic?
   Mei-Rong Li, Mei-Xia Chen, Wei-Dong Han, Xiao-Bing Fu · 2010 · Ageing Research Reviews
8. Challenges of using pluripotent stem cells for safety assessments of substances.
   K. Vojnits, S. Bremer · 2010 · Toxicology
9. Potential application of cell reprogramming techniques for cancer research
   Shigeo Saito, Ying‐Chu Lin, Yukio Nakamura, Richard Eckner, Kenly Wuputra, Kung‐Kai Kuo, Chang‐Shen Lin, Kazunari K. Yokoyama · 2018 · Cellular and Molecular Life Sciences
10. Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    I. El-Battrawy, S. Lang, Zhi-Han Zhao, I. Akin, Gökhan Yücel, Sophie Meister, Bence Patocskai, M. Behnes, B. Rudic, E. Tülümen et al. · 2016 · PLoS ONE
11. Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine
    Olivier Botman, Christine Wyns · 2014 · Frontiers in Surgery
12. Stability of genomic imprinting in human induced pluripotent stem cells
    H. Hiura, M. Toyoda, Hiroaki Okae, M. Sakurai, N. Miyauchi, Akiko Sato, N. Kiyokawa, H. Okita, Yoshitaka Miyagawa, H. Akutsu et al. · 2013 · BMC Genetics
13. Possible linkages between the inner and outer cellular states of human induced pluripotent stem cells
    Shigeru Saito, Yasuko Onuma, Yuzuru Ito, H. Tateno, M. Toyoda, H. Akutsu, Koichiro Nishino, Emi Chikazawa, Yoshihiro Fukawatase, Yoshitaka Miyagawa et al. · 2011 · BMC Systems Biology
14. Current progress and prospects of induced pluripotent stem cells
    Lingyi Chen, Lin Liu · 2009 · Science in China Series C Life Sciences
15. The prospect of induced pluripotent stem cells for diabetes mellitus treatment
    A. Soejitno, P. Prayudi · 2011 · Therapeutic Advances in Endocrinology and Metabolism
16. Sweat gland regeneration: Current strategies and future opportunities.
    Run-Kai Chen, Ziying Zhu, Shuai-fei Ji, Zhi-Jun Geng, Qian Hou, Xiao-Yan Sun, Xiao-Bing Fu · 2020 · Biomaterials
17. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons
    Federica Bono, P. Savoia, Adele Guglielmi, M. Gennarelli, G. Piovani, S. Sigala, D. Leo, S. Espinoza, R. Gainetdinov, P. Devoto et al. · 2017 · Molecular Neurobiology
18. Physiological Oxygen Prevents Frequent Silencing of the DLK1-DIO3 Cluster during Human Embryonic Stem Cells Culture
    Pingyuan Xie, Yi Juan Sun, Qi Ouyang, Liang Hu, Yue‐Qiu Tan, Xiaoying Zhou, Bo Xiong, Qianjun Zhang, Yuan Ding, Yi Pan et al. · 2013 · Stem Cells
19. Thinking outside the liver: Induced pluripotent stem cells for hepatic applications
    Mekala Subba Rao · 2013 · World Journal of Gastroenterology
20. Germline-Competent Mouse-Induced Pluripotent Stem Cell Lines Generated on Human Fibroblasts without Exogenous Leukemia Inhibitory Factor
    Chun-Liang Li, Hong-Yao Yu, Yu Ma, Guilai Shi, Jing Jiang, Jun-Jie Gu, Ying Yang, Shi-Bo Jin, Zhe Wei, Hua Jiang et al. · 2009 · PLoS ONE
21. Human Induced Pluripotent Stem Cells from Basic Research to Potential Clinical Applications in Cancer
    T. de Souza Fernandez, C. de Souza Fernandez, A. Mencalha · 2013 · BioMed Research International
22. Human Stem Cell Modeling in Neurofibromatosis type 1 (NF1)
    Michelle L. Wegscheid, C. Anastasaki, D. Gutmann · 2017 · Experimental Neurology
23. Induced Pluripotent Stem Cells
    Kitchener D. Wilson, Joseph C. Wu · 2015 · Journal of the American Medical Association (JAMA)
24. A microRNA‐Based System for Selecting and Maintaining the Pluripotent State in Human Induced Pluripotent Stem Cells
    B. D. Di Stefano, S. Maffioletti, B. Gentner, Federica Ungaro, Giulia Schira, L. Naldini, V. Broccoli · 2011 · Stem Cells
25. Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
    Ji Woong Han, Young‐sup Yoon · 2011 · Antioxidants and Redox Signaling
26. Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation
    Tobias Grass, Zeynep Dokuzluoglu, Felix Büchner, Ines Rosignol, Joshua Thomas, A. Caldarelli, Anna Dalinskaya, Jutta Becker, Fabian Rost, Michele Marass et al. · 2024 · Cell Reports Medicine
27. Highly Efficient MicroRNA Delivery Using Functionalized Carbon Dots for Enhanced Conversion of Fibroblasts to Cardiomyocytes
    Lei Yang, S. Xue, Mingjun Du, F. Lian · 2021 · International Journal of Nanomedicine
28. Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
    Zi-Zhen Si, Xi-Di Wang · 2021 · Journal of Pharmacology and Experimental Therapeutics
29. mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome
    Emeline Crutcher, Rituraj Pal, F. Naini, Ping Zhang, M. Laugsch, Jean J. Kim, A. Bajić, C. Schaaf · 2019 · Scientific Reports
30. De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency
    Masaki Yagi, Mio Kabata, Tomoyo Ukai, Sho Ohta, A. Tanaka, Yui Shimada, M. Sugimoto, K. Araki, K. Okita, K. Woltjen et al. · 2019 · Stem Cell Reports
31. Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons.
    N. Tran, I. Ladran, K. Brennand · 2013 · Schizophrenia bulletin
32. Biological characteristics of dental pulp stem cells and their potential use in regenerative medicine.
    M. Honda, H. Ohshima · 2022 · Journal of Oral Biosciences
33. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics.
    Amirhosein Maali, F. Maroufi, Farzin Sadeghi, A. Atashi, Reza Kouchaki, M. Moghadami, M. Azad · 2021 · Epigenomics
34. New In Vitro Models to Study Amyotrophic Lateral Sclerosis
    Monika A. Myszczynska, L. Ferraiuolo · 2016 · Brain Pathology
35. Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.
    Swetha Rudraiah, Philip R. Rohrer, Igor Gurevich, Michael J. Goedken, T. Rasmussen, R. Hines, J. Manautou · 2014 · Toxicological Sciences
36. A Comprehensive System for Generation and Evaluation of Induced Pluripotent Stem Cells Using piggyBac Transposition
    Tomoyuki Tsukiyama, Megumi Kato‐Itoh, Hiromitsu Nakauchi, Yasuhide Ohinata · 2014 · PLoS ONE
37. In Vitro Characterization and Engraftment of Adipocytes Derived from Human Induced Pluripotent Stem Cells and Embryonic Stem Cells
    M. Noguchi, K. Hosoda, Maiko Nakane, Eisaku Mori, K. Nakao, Daisuke Taura, Yuji Yamamoto, T. Kusakabe, M. Sone, H. Sakurai et al. · 2013 · Stem Cells and Development
38. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)
    V. Spinelli, P. Guillot, P. de Coppi · 2013 · Organogenesis
39. Intercellular Transport of Oct4 in Mammalian Cells: A Basic Principle to Expand a Stem Cell Niche?
    H. Rolf, S. Niebert, M. Niebert, Lena Gaus, H. Schliephake, K. Wiese · 2012 · PLoS ONE
40. An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells.
    Florian Hermann, M. Kjaergaard, Cheng-Lei Tian, Ulf Tiemann, Abigail Jackson, L. R. Olsen, Maria Kraft, P. Carlsson, Iina M. Elfving, J. Kettunen et al. · 2022 · Cell Stem Cell
41. From skin to the treatment of diseases – the possibilities of iPS cell research in dermatology
    Marta Gałach, J. Utikal · 2011 · Experimental Dermatology
42. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity
    Mahboubeh Farokhpour, Khadijeh Karbalaie, Somayeh Tanhaei, Marzeyeh Nematollahi, Mahmoud Etebari, M. Hamid, Mohammad Hossein Nasr‐Esfahani, Hossein Baharvand · 2009 · Toxicology in Vitro
43. Guidelines for establishing a 3-D printing biofabrication laboratory.
    Henry W. Sanicola, C. Stewart, Michael Mueller, F. Ahmadi, Dadong Wang, Sean K. Powell, Korak Sarkar, K. Cutbush, M. Woodruff, David A. Brafman · 2020 · Biotechnology Advances
44. Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
    Akihito Hishikawa, K. Hayashi, H. Itoh · 2018 · Molecules
45. Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney
    Letizia De Chiara, J. Crean · 2016 · Journal of Clinical Medicine
46. The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges
    M. Khazaei, Ahad M. Siddiqui, M. Fehlings · 2014 · Journal of Clinical Medicine
47. Reprogramming cell fates: insights from combinatorial approaches
    C. Pereira, I. Lemischka, K. Moore · 2012 · Annals of the New York Academy of Sciences
48. Mending a broken heart: In vitro, in vivo and in silico models of congenital heart disease
    A. J. Rufaihah, Ching-Kit Chen, C. Yap, C. Mattar · 2021 · Disease Models & Mechanisms
49. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
    Samantha Seah, Chadi A. El Farran, Tushar Warrier, Jian Xu, Yuin‐Han Loh · 2015 · International Journal of Molecular Sciences
50. Cholesterol-Secreting and Statin-Responsive Hepatocytes from Human ES and iPS Cells to Model Hepatic Involvement in Cardiovascular Health
    W. Krueger, Borko Tanasijevic, Vanessa Barber, A. Flamier, Xin-Sheng Gu, J. Manautou, T. Rasmussen · 2013 · PLoS ONE
51. Biologic Foundations for Skeletal Tissue Engineering
    E. Bueno, J. Glowacki · 2011 · Synthesis lectures on tissue engineering
52. Pluripotency rush! Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells.
    A. Beltrami, D. Cesselli, C. Beltrami · 2009 · Pharmacology and Therapeutics
53. Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity.
    Daniel P Neumann, G. Goodall, Philip A. Gregory · 2017 · Seminars in Cell and Developmental Biology
54. NANOG priming before full reprogramming may generate germ cell tumours.
    I. Grad, Y. Hibaoui, M. Jaconi, L. Chicha, R. Bergström-Tengzelius, Sailani, M. Pelte, S. Dahoun, Ta Mitsiadis, V. Töhönen et al. · 2011 · European Cells & Materials
55. Transcriptional control of embryonic and induced pluripotent stem cells.
    M. Guenther · 2011 · Epigenomics
56. Current situation and future of stem cells in cardiovascular medicine.
    M. Nasser, Xiao Qi, Shuo-Ji Zhu, Yinru He, Ming-Yi Zhao, Hui-Ming Guo, P. Zhu · 2020 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
57. Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming
    Pengfei Ji, S. Manupipatpong, Nina Xie, Yu-Jing Li · 2016 · Stem Cells International
58. Genetic instability in human embryonic stem cells: prospects and caveats.
    Thierry Nouspikel · 2013 · Future Oncology
59. Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos
    A. Taei, H. Gourabi, A. Seifinejad, M. Totonchi, Ebrahim Shahbazi, M. R. Valojerdi, P. Eftekhari, L. Karimian, H. Baharvand · 2010 · In Vitro Cellular & Developmental Biology - Animal
60. Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems.
    Jun Li, Yun-Fei Bai, Yang Liu, Zhongya Song, Yong Yang, Yang Zhao · 2023 · Cell Reports
61. Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
    Sevda Gheibi, T. Singh, J. P. D. da Cunha, M. Fex, H. Mulder · 2020 · Cells
62. Reprogramming of the MHC‐I and Its Regulation by NFκB in Human‐Induced Pluripotent Stem Cells
    M. Pick, D. Ronen, Ofra Yanuka, N. Benvenisty · 2012 · Stem Cells
63. The Interface of Gene Editing with Regenerative Medicine
    Veronica E. Farag, Elsie Devey, Kam W. Leong · 2024 · Engineering
64. Application of Cord Blood and Cord Blood-Derived Induced Pluripotent Stem Cells for Cartilage Regeneration
    Yeri Alice Rim, Yoojun Nam, J. Ju · 2018 · Cell Transplantation
65. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
    Wen-Wen Deng, Xia Cao, Jing-Jing Chen, Zhi-Jian Zhang, Qing-Tong Yu, Yan Wang, Gen-Bao Shao, Jie Zhou, Xiang-Dong Gao, Jiang-Nan Yu et al. · 2015 · ACS Applied Materials and Interfaces
66. Late Passage Human Fibroblasts Induced to Pluripotency Are Capable of Directed Neuronal Differentiation
    Jun Liu, Hüseyin Sümer, Jessie Leung, Kyle R. Upton, Mirella Dottori, Alice Pébay, Paul John Verma · 2010 · Cell Transplantation
67. De- and re-differentiation of the melanocytic lineage.
    L. Larribère, J. Utikal · 2014 · European Journal of Cell Biology
68. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells
    Yin-Chu Lin, Cha-Chien Ku, Kenly Wuputra, Chung-Jung Liu, Deng-Chyang Wu, Maki Satou, Yukio Mitsui, S. Saito, K. Yokoyama · 2024 · International Journal of Molecular Sciences
69. Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies
    Raffaella Adami, Daniele Bottai · 2019 · Stem Cell Reviews and Reports
70. Characterization of mesenchymal progenitor cells in the crown and root pulp of primary teeth.
    Taku Toriumi, Naoya Takayama, Miyako Murakami, Momoko Sato, Maki Yuguchi, Yosuke Yamazaki, K. Eto, M. Otsu, H. Nakauchi, Tetsuo Shirakawa et al. · 2015 · Biomedical research
71. Induced pluripotent stem cells – alchemist's tale or clinical reality?
    S. Tamir Rashid, Ludovic Vallier · 2010 · Expert Reviews in Molecular Medicine
72. A histone methylation code for SV40 minichromosomes
    Matilde Todaro, Y. Lombardo, G. Stassi · 2010 · Cell Cycle
73. Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts
    Katherine Ilia, Nika Shakiba, Trevor Bingham, Ross D. Jones, Michael M. Kaminski, Eliezer Aravera, S. Bruno, Sebastian Palacios, Ron Weiss, James J. Collins et al. · 2023 · Science Advances
74. A susceptibility locus on chromosome 13 profoundly impacts the stability of genomic imprinting in mouse pluripotent stem cells
    E. Swanzey, T. Mcnamara, E. Apostolou, Mamta Tahiliani, M. Stadtfeld · 2020 · bioRxiv
75. The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method
    Yajun Liu, De Cheng, Zhenzhen Li, Xing Gao, Hua-Yan Wang · 2012 · Genetics and Molecular Biology
76. Induced Pluripotent Stem Cells: A New Approach for Physiological Research
    Kurt Pfannkuche, Tobias Hannes, Markus Khalil, Monireh Soroush Noghabi, Amir Morshedi, Jürgen Hescheler, Peter Dröge · 2010 · Cellular Physiology and Biochemistry
77. Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs)
    Michele Manganelli, E. L. Mazzoldi, R. Ferraro, Marinella Pinelli, Marta Parigi, Seyed Ali Mir Aghel, M. Bugatti, G. Collo, Gabriele Stocco, W. Vermi et al. · 2024 · Stem Cell Reviews and Reports
78. On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations
    Samantha Wu, K. Fitzgerald, J. Giordano · 2018 · Frontiers in Neurology
79. Stem cell contributions to neurological disease modeling and personalized medicine
    Nicholas Liang, Cleber A. Trujillo, Priscilla Davidson Negraes, Alysson Renato Muotri, Claudiana Lameu, Henning Ulrich · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
80. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Laura Jung, P. Tropel, Y. Moal, Marius Teletin, E. Jeandidier, R. Gayon, Christian Himmelspach, Fiona Bello, Cécile André, Adeline Tosch et al. · 2014 · Molecular human reproduction
81. Derivation, Propagation, and Characterization of Neuroprogenitors from Pluripotent Stem Cells (hESCs and hiPSCs)
    Khun H. Lie, Henry C. Y. Chung, Kuldip Sidhu · 2012 · Methods in molecular biology
82. Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.
    Andrew A. Buckley, Shaye B. Hagler, Vivien Lettry, J. Bago, Spencer M. Maingi, S. Khagi, M. Ewend, C. Miller, S. Hingtgen · 2020 · Molecular Therapy
83. Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy
    Annie Lee, Chandana Kondapalli, D. Virga, Tommy L. Lewis, So-Ye-On Koo, A. Ashok, Georges Mairet-Coello, S. Herzig, R. Shaw, Andrew A. Sproul et al. · 2019 · bioRxiv
84. Basal glucocorticoid receptor activation induces proliferation and inhibits neuronal differentiation of human induced pluripotent stem cell-derived neuronal precursor cells.
    Elina Nürnberg, S. Horschitz, P. Schloss, A. Meyer-Lindenberg · 2018 · Journal of Steroid Biochemistry and Molecular Biology
85. Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neurons.
    S. Horschitz, Friederike Matthäus, Anja Gross, J. Rosner, Marta Gałach, W. Greffrath, R. Treede, J. Utikal, P. Schloss, A. Meyer-Lindenberg · 2015 · Stem Cell Research
86. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms
    Yan-Ning Cai, X. Dai, Qian-hua Zhang, Zhiming Dai · 2015 · Diagnostic Pathology
87. Gene therapy using stem cells.
    Erin R. Burnight, L. A. Wiley, R. Mullins, E. Stone, B. Tucker · 2015 · Cold Spring Harbor Perspectives in Medicine
88. Derivation and Long‐Term Culture of Transgene‐Free Human Induced Pluripotent Stem Cells on Synthetic Substrates
    L. Villa-Diaz, J. K. Kim, J. Lahann, P. Krebsbach · 2014 · Stem Cells Translational Medicine
89. Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level
    Dan-Dan Sui, Zhaolin Sun, Chun-Long Xu, Yuan-Yuan Wu, M. Capecchi, Sen Wu, Ning Li · 2014 · Stem Cell Reports
90. Concise Review: The Dynamics of Induced Pluripotency and Its Behavior Captured in Gene Network Motifs
    M. Muraro, H. Kempe, P. Verschure · 2013 · Stem Cells
91. Generation of a Drug-inducible Reporter System to Study Cell Reprogramming in Human Cells*
    Sergio Ruiz, Athanasia D. Panopoulos, N. Montserrat, M. Multon, Aurélie Daury, Corinne Rocher, E. Spanakis, E. Batchelder, C. Orsini, J. Deleuze et al. · 2012 · Journal of Biological Chemistry
92. The genomic stability of induced pluripotent stem cells
    Zhao Chen, Tongbiao Zhao, Yang Xu · 2012 · Protein & Cell
93. Regenerative Medicine
    Benjamin T. Corona, C. Ward, B. Harrison, G. Christ · 2010 · Journal of Investigative Medicine
94. Efficient derivation of excitatory and inhibitory neurons from human pluripotent stem cells stably expressing direct reprogramming factors
    Saera Song, A. Ashok, Damian J. Williams, Maria E. Kaufman, K. Duff, Andrew A. Sproul · 2021 · Current Protocols
95. Reprogramming, oscillations and transdifferentiation in epigenetic landscapes
    Bivash Kaity, Ratan Sarkar, Buddhapriya Chakrabarti, Mithun Kumar Mitra · 2018 · Scientific Reports
96. Cell-based therapies of liver diseases: age-related challenges
    K. N. Yarygin, A. Lupatov, I. Kholodenko · 2015 · Clinical Interventions in Aging
97. A poor imitation of a natural process
    Ye-Min Zhang, Lin Yao, Xi-Ya Yu, Jun Ou, Ning Hui, Shan-Rong Liu · 2012 · Cell Cycle
98. Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration
    K. Boheler · 2010 · Thrombosis and Haemostasis
99. Long-term multilayer adherent network (MAN) expansion, maintenance, and characterization, chemical and genetic manipulation, and transplantation of human fetal forebrain neural stem cells.
    D. R. Wakeman, M. Hofmann, D. Redmond, Yang D. Teng, Evan Y. Snyder · 2009 · Current protocols in stem cell biology
100. Mouse and human pluripotent stem cells and the means of their myogenic differentiation.
     I. Grabowska, K. Archacka, A. Czerwińska, M. Krupa, M. Ciemerych · 2012 · Results and problems in cell differentiation